MENU

Rising Tension Between US and China Elevates Trading Issues

Chris Kushlis, Fixed Income Sovereign Analyst, Asian Markets
Eric Veiel, Co‐head, Global Equity
Katie Deal, Washington Analyst, US Equity Division

  • Read Time: 5 mins

US measures could increase oversight of Chinese companies

Key insights

  • “Tough on China” policies could limit trading of Chinese securities on US exchanges.

  • Pressure mounts to subject Chinese companies to the same accounting scrutiny faced by other public companies traded in the US.

  • Federal and state government retirement funds are facing pressure to restrict investment in Chinese companies.

With China becoming a high‑profile issue in the US presidential election, much of the friction has centered on trade disputes and the coronavirus outbreak. Several efforts are also underway in the US to address a longer‑standing issue: whether Chinese companies are creating risks to investors and markets by skirting US audits and regulatory oversight. How these legislative and regulatory issues evolve could have implications for financial markets, including potential limitations on the trading of Chinese securities.

Though the measure’s future is uncertain, key members of Congress are committed to heightening the regulatory risk profiles of Chinese firms.

Potential Ban of Chinese Securities on US Exchanges

The US Congress and US regulators are furthering efforts to prevent companies in emerging markets, particularly those in China, from seeking to benefit from US capital markets if they do not undergo the same level of oversight as companies in the US and other developed market countries. An estimated 224 US listed companies with about USD 1.8 trillion in market capitalization could be impacted by the legislative and regulatory measures1.

Congress is considering legislation that could lead to the delisting of Chinese securities traded on US stock exchanges unless the companies accept regular public review and oversight of their accounting practices. In addition, Nasdaq has proposed new rules that would codify its authority to apply more stringent listing criteria of companies in “restrictive markets” due to concerns about a company’s auditor, inadequate disclosures, a lack of transparency from certain emerging markets, and a need for greater accountability and access to information.

These are long‑standing regulatory concerns, as Chinese firms have raised billions of dollars by listing their shares on US stock exchanges while avoiding the auditing scrutiny that other public firms must submit to. For years, the Public Company Accounting Oversight Board (PCAOB), which oversees the audits of public companies, has flagged “China Related Access Challenges” that have hindered the agency’s capacity to gain “complete and timely access” for inspections and investigations of Chinese public companies.

In the US Congress, the Senate has approved a bill aimed at tighter regulations, while the House is considering similar legislation. The Senate bill, Holding Foreign Companies Accountability Act, would require certain companies to disclose whether they are “owned or controlled by a foreign government” and would potentially prohibit the trading of securities of US‑listed companies audited by firms that the PCAOB cannot inspect.

The goal is to ensure that the PCAOB has access to inspect Chinese audit firms in the same manner as they inspect US audit firms and those located in other nations. Thus, it would allow the PCAOB to audit their financials at least every three years. Companies that do not comply with these requirements could face delisting from US exchanges.

“Though the measure’s future is uncertain, key members of Congress are committed to heightening the regulatory risk profiles of Chinese firms,” said Katie Deal, Washington Analyst, US Equity Division. Any delisting would not happen until 2025, so affected companies would have time to relocate their listings or put in place the required measures to comply.

Several of China’s largest technology firms are listed in the US, but they have the capacity to shift their listings as offerings in Hong Kong. In fact, most of T. Rowe Price’s foreign holdings consist of Chinese American Depository Receipts (ADRs), which also have secondary listings on the Hong Kong Exchange, enabling the firm to exchange ADR shares for the Hong Kong listing with minimal impact to portfolios. However, several operational processes would have to be established with some clients to allow for trading on non‑US exchanges. In addition, custodian relationships may need to be set up on a global platform. Eric Veiel, co‑head, Global Equity, says the firm “continually monitors risks to our holdings, including regulatory factors. Predicting regulatory events is especially difficult; as a result, sentiment around regulatory risk can lead to large short‑term movements in stock prices. Our team of analysts and portfolio managers draw upon deep industry contacts as well as their own experiences and insights to assess these situations. We continue to monitor this situation and its implications for individual companies.”

Source: Fortune magazine.

Restricting Investment in Chinese Securities

Scrutiny of Chinese companies could also impact the retirement savings of federal and state workers. The US Federal Retirement Thrift Investment Board (FRTIB), which manages federal government retirement funds, has decided to put on hold its plan to shift USD 593.7 billion from the Thrift Savings Plan’s I Fund benchmark MSCI EAFE Index of developed markets to the MSCI ACWI ex USA Investable Market Index, which includes China and other emerging markets. 

The Board cited concerns about the potential impact of the coronavirus on emerging markets “because those markets are going to be challenged and we’re not sure what they’re going to look like over the next two or three years,” said Michael D. Kennedy, chairman of the FRTIB. However, the Board also was under heavy pressure from the Trump administration to reverse the earlier decision. On May 4, President Donald Trump nominated three people to the five‑member Board that, upon Senate confirmation, could lead to a new majority. The Board also received letters from administration officials citing “national security and humanitarian concerns for the United States.”

State retirement plans may face similar pressure. Florida Senator Marco Rubio and Congressman Michael Waltz sent a letter to Florida’s governor and other officials demanding that they divest state retirement money from Chinese companies. Governor Ron DeSantis has said he may push for that in 2021.

“The reversal by the federal government is a symbolic move, but it is not expected to have a significant immediate financial impact on China,” says Chris Kushlis, Fixed Income Sovereign Analyst, Asian Markets. “What could be more meaningful is if other public pension plans at the state and local levels in the US also come under pressure to exclude Chinese securities. That’s important to monitor.”

202006‑1226191

202007-1234599

Sign up for US Equity insights from T. Rowe Price

Share this article:

Share on linkedin
Share on email
Important Information
 
The specific securities identified and described are for informational purposes only and do not represent recommendations.
 
This material is being furnished for general informational and/or marketing purposes only. The material does not constitute or undertake to give advice of any nature, including fiduciary investment advice, nor is it intended to serve as the primary basis for an investment decision. Prospective investors are recommended to seek independent legal, financial and tax advice before making any investment decision. T. Rowe Price group of companies including T. Rowe Price Associates, Inc. and/or its affiliates receive revenue from T. Rowe Price investment products and services. Past performance is not a reliable indicator of future performance. The value of an investment and any income from it can go down as well as up. Investors may get back less than the amount invested. The material does not constitute a distribution, an offer, an invitation, a personal or general recommendation or solicitation to sell or buy any securities in any jurisdiction or to conduct any particular investment activity. The material has not been reviewed by any regulatory authority in any jurisdiction. Information and opinions presented have been obtained or derived from sources believed to be reliable and current; however, we cannot guarantee the sources’ accuracy or completeness. There is no guarantee that any forecasts made will come to pass. The views contained herein are as of the date written and are subject to change without notice; these views may differ from those of other T. Rowe Price group companies and/or associates. Under no circumstances should the material, in whole or in part, be copied or redistributed without consent from T. Rowe Price. The material is not intended for use by persons in jurisdictions which prohibit or restrict the distribution of the material and in certain countries the material is provided upon specific request. It is not intended for distribution to retail investors in any jurisdiction.
 
UK—This material is issued and approved by T. Rowe Price International Ltd, 60 Queen Victoria Street, London, EC4N 4TZ which is authorised and regulated by the UK Financial Conduct Authority. For Professional Clients only.
 
© 2020 T. Rowe Price. All rights reserved. T. ROWE PRICE, INVEST WITH CONFIDENCE, and the bighorn sheep design are, collectively and/or apart, trademarks or registered trademarks of T. Rowe Price Group, Inc. ID0003298 (05/2020) 202005‑1183620

You might be interested in…

See our comprehensive range of US equity funds

Thank you for registering for US equities updates. The latest insights will be sent straight to your inbox, in the meantime access our latest thinking:

Important Legal Information

This site is intended for financial intermediaries in the United Kingdom. I have read the terms detailed below and confirm that I am a financial intermediary and that I wish to proceed. By accessing this website, you consent to T. Rowe Price collecting information by way of cookies.

Information contained in the T. Rowe Price website is not intended for investors in any jurisdiction in which distribution or purchase is not authorised, including the jurisdiction of the reader of this information, where applicable. For example, the information herein is not for distribution to and does not constitute an offer to sell or the solicitation of any offer to buy any securities in the United States of America to or for the benefit of United States persons.

Information obtained from this site is intended specifically for the individuals who have agreed to these Terms and Conditions and may not be redistributed without prior consent from the T. Rowe Price Legal department.

The information is designed for professional investors, including financial intermediaries or members of the media, and is published for informational purposes only. In particular, the information is directed at only informing persons falling within one or more of the following categories:

(a) A government;
(b) A bank or insurance company;
(c) A pension fund or charity;
(d) Persons whose ordinary activities involve them, as principal or as agent, in acquiring, holding, managing or disposing of investments for the purposes of a business carried on by them or whom it is reasonable to expect will, acquire, manage or dispose of investments for the purpose of such a business;
(e) Persons whose ordinary business involves the giving of advice, which may lead to another person acquiring or disposing of an investment or refraining from so doing;
(f) Representatives of the media for corporate and background information about T. Rowe Price.

Persons who do not fall into one of the above categories should not act upon the information contained herein.

Certain persons may have access to information regarding the T. Rowe Price Funds SICAV, an investment company incorporated as “Société d’Investissement à Capital Variable” (‘SICAV’) under the laws of Luxembourg and the T. Rowe Price Funds OEIC, an open-ended investment company (‘OEIC’) incorporated in England and Wales. The sub-funds referred to on the site are only offered by the current prospectus. The prospectus contains more complete information about the sub-funds, including investment objectives, charges and expenses. However, the prospectus and other information relating to the sub-funds will not be intentionally distributed to persons in any country where such distribution would be contrary to local law or regulation.

Past performance is not a guide to future performance. The value of securities and any income generated from them might decrease as well as increase. Changes in rates of exchange may also have an adverse effect on the value, price or income of securities. Investors should also be aware of the additional risks associated with investments in emerging markets, high yield securities and smaller companies.

This information herein does not constitute investment advice and the products described may not be available to or suitable for all investors. You should consider, if appropriate, obtaining independent professional advice before making an investment decision.

Unless otherwise noted, the content appearing in this Section of the T. Rowe Price website has been issued by T. Rowe Price International Ltd, 60 Queen Victoria Street, London EC4N 4TZ, which is authorised and regulated by the U.K. Financial Conduct Authority with the reference number 194667.